首页> 外文OA文献 >Pretransplant conditioning with IV busulfan (Bu) and fludarabine (Flu) as alternative to Bu and cyclophosphamide (Cy)—a safe, myeloablative regimen with high antileukemic efficacy in AML/MDS

【2h】

Pretransplant conditioning with IV busulfan (Bu) and fludarabine (Flu) as alternative to Bu and cyclophosphamide (Cy)—a safe, myeloablative regimen with high antileukemic efficacy in AML/MDS

机译：移植前用IV丁硫磺（Bu）和氟达拉滨（Flu）代替Bu和环磷酰胺（Cy）进行预处理-一种安全，清髓的方案，在AML / MDS中具有高抗白血病功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
de Lima M.; Couriel D.; Shahjahan M.; Alamo J.; Madden T.; Thapar N.; Russell J.; Anderlini P.; Giralt S.; Shpall E.; Jones R.; Champlin R.; Andersson B.;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. [J] . Andersson BS, de-Lima M, Thall PF, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2008,第6期

机译：每天一次白消安和氟达拉滨（Bu-Flu静脉注射）比静脉注射更有利。白消安和环磷酰胺（i.v. BuCy2）作为AML / MDS中的移植前调节疗法。
2. A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33 + AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen [J] . SatwaniP., BhatiaM., GarvinJ.H., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2012,第2期

机译：CD33 + AML不良儿童患儿吉莫单抗唑佐米星（GO）与环丁硫唑和环磷酰胺（Bu / Cy）联合同种异体干细胞移植的I期研究：一种新的靶向免疫化学疗法清髓疗法（MAC）方案
3. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [J] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性
4. Once Daily IV Busulfan and Fludarabine (IV Bu-Flu) Compares Favorably with IV Busulfan and Cyclophosphamide (IV BuCy2) as Pretransplant Conditioning Therapy in AML/MDS [O] . Borje S. Andersson, Marcos de Lima, Peter F. Thall, -1

机译：每日一次静脉使用白消安和氟达拉滨（IV Bu-Flu）优于静脉注射白消安和环磷酰胺（IV BuCy2）作为AML / MDS中的移植前条件治疗
5. Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS [O] . Andersson Borje S., de Lima Marcos, Thall Peter F., 2008

机译：每日一次白消安和氟达拉滨（i.v. Bu-Flu）与i.v.比较白消安和环磷酰胺（i.v. BuCy2）作为AML / MDS中的移植前条件疗法

Pretransplant conditioning with IV busulfan (Bu) and fludarabine (Flu) as alternative to Bu and cyclophosphamide (Cy)—a safe, myeloablative regimen with high antileukemic efficacy in AML/MDS

著录项

引文网络

相似文献

相关主题

期刊订阅